Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00398177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv26
  2. Site contact updatedv25
  3. 4 versions Re-verified since Apr 20, 2020, no change to tracked fieldsv21-v24
  4. Completion date: Jan 2099 Site contact updatedv20 Show all 2 changesShow less
    • Site contact updated
  5. Primary completion date: Jun 2016 to Jan 2099 Completion date: Jun 2017 to not stated · Start date: Jun 1999 to Jan 1999v19 Show all 3 changesShow less
    • Completion date: Jun 2017 to not stated
    • Start date: Jun 1999 to Jan 1999
Show 17 earlier versionsHide 17 earlier versions
  1. Eligibility criteria expanded, about 45 wordsv18 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  2. Site contact updatedv17
  3. Site contact updatedv16
  4. Study Status, Outcome Measuresv15
  5. 2 versions Re-verified since Jul 5, 2012, no change to tracked fieldsv13-v14
  6. Completion date: Jun 2017 Collaborators: 3 to 2v12 Show all 2 changesShow less
    • Collaborators: 3 to 2

    See this version in full on ClinicalTrials.gov ↗

  7. Re-verified, no change to tracked fieldsv11
  8. Site contact updatedv10
  9. Primary completion date: Jun 2016 Eligibility criteria revisedv9 Show all 2 changesShow less
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  10. Eligibility criteria revised Site contact updatedv8 Show all 2 changesShow less
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  11. Re-verified, no change to tracked fieldsv7
  12. Site contact updated Collaborators: 4 to 3v6 Show all 2 changesShow less
    • Collaborators: 4 to 3

    See this version in full on ClinicalTrials.gov ↗

  13. Enrollment target: 9999 Eligibility criteria revised · Study site revised · Collaborators expanded, about 13 wordsv5 Show all 4 changesShow less
    • Eligibility criteria revised
    • Study site revised
    • Collaborators expanded, about 13 words

    See this version in full on ClinicalTrials.gov ↗

  14. Re-verified, no change to tracked fieldsv4
  15. Eligibility criteria expanded, about 8 wordsv3 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  16. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Trial Details
NCT Number NCT00398177
Lead Sponsor Stanford University
Collaborators: The Leukemia and Lymphoma Society, Biospect Inc
Conditions Lymphoma, Non-Hodgkin, Hodgkin's Disease
Enrollment 9,999 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov